Skip to main content
. Author manuscript; available in PMC: 2012 Sep 18.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Aug 15;60(Suppl 3):S96–104. doi: 10.1097/QAI.0b013e31825eb27b

FIGURE 1.

FIGURE 1

Number of generic versus branded drugs procured (monthly packs, 2005–2010). PEP-FAR increased its use of generic drugs from 16% in 2005 to 97% in 2010.